Whitehawk Therapeutics, Inc. Income Statement

Income Statement Dec2010 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.00M-0.00M-0.01M-0.01M-0.01M-0.01M20.16M14.00M14.00M15.22M24.35M25.98M
Cost of Revenue 1.33M2.81M3.02M
Gross Profit -0.00M-0.00M-0.01M-0.01M-0.01M-0.01M20.16M14.00M14.00M13.88M21.55M22.96M
Operating items
Research & Development 17.85M12.82M15.01M19.67M32.66M48.93M51.03M
Selling, General & Administrative 0.02M0.02M0.02M0.02M0.02M0.03M13.49M9.76M2.12M18.51M40.18M44.55M36.75M
Restructuring Costs 2.64M
Other Operating Expenses 1.86M74.16M5.06M2.81M3.02M
Operating Expenses 0.02M0.02M0.02M0.02M0.02M0.03M31.34M24.44M17.13M112.34M77.90M96.29M93.44M
Operating Income -0.02M-0.02M-0.02M-0.02M-0.02M-0.03M-11.18M-24.44M-2.55M-111.22M-62.68M-71.93M-67.46M
EBIT -0.02M-0.02M-0.02M-0.02M-0.02M-0.03M-11.18M-24.44M-2.55M-111.22M-62.68M-71.93M-67.46M
Non-operating items
Interest & Investment Income 0.78M1.03M0.04M0.01M2.40M6.40M3.92M
Other Non Operating Income -0.93M1.13M2.17M6.17M3.77M
Non Operating Income 0.78M1.17M-0.93M1.13M2.17M6.17M3.77M
Net income details
EBT -0.02M-0.03M-0.03M-0.03M-0.03M-0.04M-10.40M-23.41M-3.48M-110.09M-60.51M-65.77M-63.69M
Tax Provisions 0.00M0.00M
Profit After Tax -0.02M-0.03M-0.03M-0.03M-0.03M-0.04M-10.40M-23.27M-3.50M-110.10M-60.51M-65.77M-63.70M
Income from Continuing Operations -0.02M-0.03M-0.03M-0.03M-0.03M-0.04M-10.40M-23.41M-3.48M-110.09M-60.51M-65.77M-63.69M
Consolidated Net Income -0.02M-0.03M-0.03M-0.03M-0.03M-0.04M-10.40M-23.41M-3.48M-110.09M-60.51M-65.77M-63.69M
Income towards Parent Company -0.02M-0.03M-0.03M-0.03M-0.03M-0.04M-10.40M-23.41M-3.48M-110.09M-60.51M-65.77M-63.69M
Preferred Dividend Payments 0.65M
Net Income towards Common Stockholders -0.02M-0.03M-0.03M-0.03M-0.03M-0.04M-10.40M-23.27M-4.32M-110.74M-60.51M-65.77M-63.69M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.33M1.80M2.71M2.71M3.14M20.89M24.40M24.53M24.65M
Shares Outstanding (Diluted Average) 8.92M22.51M26.92M27.03M
EBITDA -0.02M-0.02M-0.02M-0.02M-0.02M-0.03M-11.18M-24.44M-4.46M-110.74M-60.63M-65.62M-63.70M